Patent · US Active

Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)

US11020476B2 · kind B2 · utility

11Cited by

41References

20Claims

0Family size

Assignees

Janssen Sciences Ireland Unlimited Company · IE
Bavarian Nordic A/S · DK

Inventors

Daniel Boden · San Mateo, US
Helen Horton · Mol, BE
Jean-Marc Edmond Fernand Marie Neefs · Lier, BE
Soumitra Roy · Noordwijk, NL
Jerôme Hubertina Henricus Victor Custers · Alphen aan den Rijn, NL
Roland Christian ZAHN · Rijnsburg, NL
Markus Kalla · Penzberg, DE

Key dates

Filing date	Dec 18, 2018
Grant date	Jun 1, 2021
Priority date	—
Expiry date	Dec 18, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2730/10134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are Modified Vaccinia Ankara (MVA) vectors and adenovirus vectors encoding HBV antigens. Also provided are methods of enhancing an immune response in a human subject by utilizing the MVA and adenovirus vectors encoding HBV antigens in a prime/boost regimen to the enhance the immune response in the human subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.